These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

685 related articles for article (PubMed ID: 19531750)

  • 21. Decreased prevalence of mixed cryoglobulinemia in the HAART era among HIV-positive, HCV-negative patients.
    Kosmas N; Kontos A; Panayiotakopoulos G; Dimitrakopoulos A; Kordossis T
    J Med Virol; 2006 Oct; 78(10):1257-61. PubMed ID: 16927287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cryofibrinogenemia: a marker of severity of cryoglobulinemic vasculitis.
    Michaud M; Moulis G; Puissant B; Balardy L; Huart A; Gaches F; Cougoul P; Arlet P; Blancher A; Pourrat J; Sailler L
    Am J Med; 2015 Aug; 128(8):916-21. PubMed ID: 25827358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Initial increase in the cryoglobulin level after rituximab therapy for type II cryoglobulinemia secondary to Waldenström macroglobulinemia does not indicate failure of response.
    Ghobrial IM; Uslan DZ; Call TG; Witzig TE; Gertz MA
    Am J Hematol; 2004 Dec; 77(4):329-30. PubMed ID: 15551276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro reactivity of cryoglobulin IgM and IgG in hepatitis C virus-associated mixed cryoglobulinemia.
    Schott P; Polzien F; Müller-Issberner A; Ramadori G; Hartmann H
    J Hepatol; 1998 Jan; 28(1):17-26. PubMed ID: 9537859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Characterization of cryoglobulin, M protein, low molecular weight IgM in a patient with chronic hepatitis C and type II mixed cryoglobulinemia].
    Nishiyama Y; Shimatsu A; Arakawa M; Nagao M; Saito A; Kido A; Koganeya H; Wada T; Okuda T; Ichiyama S
    Rinsho Byori; 2001 Nov; 49(11):1139-45. PubMed ID: 11769562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical, biochemical, and histological changes in hepatitis C virus infection-associated cryoglobulinemia.
    Fayyazi A; Schott P; Hartmann H; Mihm S; Middel P; Ramadori G; Radzun HJ
    Z Gastroenterol; 1997 Oct; 35(10):921-8. PubMed ID: 9370142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Mixed cryoglobulinemia with monoclonal IgA and biclonal IgM during hepatitis C virus infection].
    Abdi S; Bahji M; Essaadouni L; Agoumi N; Adnaoui M; Tazi ZM; Maaouni A
    Ann Biol Clin (Paris); 2004; 62(3):334-7. PubMed ID: 15217768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The etiology and pathophysiology of mixed cryoglobulinemia secondary to hepatitis C virus infection.
    Agnello V
    Springer Semin Immunopathol; 1997; 19(1):111-29. PubMed ID: 9266635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular cell adhesion molecule-1 (VCAM-1) plays a central role in the pathogenesis of severe forms of vasculitis due to hepatitis C-associated mixed cryoglobulinemia.
    Kaplanski G; Maisonobe T; Marin V; Grès S; Robitail S; Farnarier C; Harlé JR; Piette JC; Cacoub P
    J Hepatol; 2005 Mar; 42(3):334-40. PubMed ID: 15710215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High values of CXCL10 serum levels in mixed cryoglobulinemia associated with hepatitis C infection.
    Antonelli A; Ferri C; Fallahi P; Ferrari SM; Sebastiani M; Ferrari D; Giunti M; Frascerra S; Tolari S; Franzoni F; Galetta F; Marchi S; Ferrannini E
    Am J Gastroenterol; 2008 Oct; 103(10):2488-94. PubMed ID: 18775023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis C virus-associated B-cell proliferation--the role of serum B lymphocyte stimulator (BLyS/BAFF).
    Sène D; Limal N; Ghillani-Dalbin P; Saadoun D; Piette JC; Cacoub P
    Rheumatology (Oxford); 2007 Jan; 46(1):65-9. PubMed ID: 16782735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [HCV infection and mixed cryoglubulinemia].
    Ignatova TM; Serov VV; Mukhin NA; Kozlovskaia LV; Milovanova SIu; Aprosina ZG
    Klin Med (Mosk); 2005; 83(6):37-43. PubMed ID: 16075643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal manifestations associated with hepatitis C virus.
    Sinico RA; Fornasieri A; D'Amico G
    Ann Med Interne (Paris); 2000 Feb; 151(1):41-5. PubMed ID: 10761561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Murine cryoglobulinemia: pathogenic and protective IgG3 self-associating antibodies.
    Berney T; Shibata T; Izui S
    J Immunol; 1991 Nov; 147(10):3331-5. PubMed ID: 1940338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis C virus infection, type III cryoglobulinemia, and necrotizing vasculitis.
    Brownell I; Fangman W
    Dermatol Online J; 2007 Jan; 13(1):6. PubMed ID: 17511939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical relevance of serum cryoglobulins in hemophilic patients with hepatitis C virus infection.
    Gandini G; Franchini M; Capra F; Aprili G
    Ann Ital Med Int; 1999; 14(4):285-7. PubMed ID: 10638020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [HCV-associated cryoglobulinemic vasculitis].
    Ter Arkh; 2012; 84(5):35-42. PubMed ID: 22830210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of cryoglobulinaemia in hepatitis C virus- and hepatitis C virus/human immunodeficiency virus-infected individuals: implications for renal function.
    Lapinski TW; Parfieniuk A; Rogalska-Plonska M; Czajkowska J; Flisiak R
    Liver Int; 2009 Sep; 29(8):1158-61. PubMed ID: 19602133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cryoglobulins and cryoglobulinemic vasculitis].
    Suszek D; Majdan M
    Wiad Lek; 2018; 71(1 pt 1):59-63. PubMed ID: 29558353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Rheumatoid factor and cryoglobulin are not efficiently related to cold activation of complement].
    Nakagawa T; Ueda K; Nakajima H; Shimizu A
    Rinsho Byori; 1995 Jan; 43(1):21-5. PubMed ID: 7884960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.